These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20620492)

  • 1. Influence of African-American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients.
    Padiyar A; Augustine JJ; Bodziak KA; Aeder M; Schulak JA; Hricik DF
    Transplant Proc; 2010 Jun; 42(5):1643-7. PubMed ID: 20620492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Knauss TC; Bodziak KA; Weigel K; Rodriguez V; Seaman D; Siegel C; Valente J; Schulak JA
    Transplantation; 2003 Sep; 76(6):938-42. PubMed ID: 14508357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients.
    Gruber SA; West MS; Sillix DH; El-Amm JM; Garnick J; Morawski K; Haririan A
    Surgery; 2005 Oct; 138(4):772-8; discussion 778-9. PubMed ID: 16269308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression.
    Boardman RE; Alloway RR; Alexander JW; Buell JF; Cardi M; First MR; Hanaway MT; Munda R; Rogers CC; Roy-Chaudhury P; Susskind B; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):814-6. PubMed ID: 15848541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.
    Gaber AO; Moore LW; Alloway RR; Woodle ES; Pirsch J; Shihab F; Henning A; Fitzsimmons W; Holman J; Reisfield R; First MR;
    Transplantation; 2013 Feb; 95(4):573-9. PubMed ID: 23423269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R
    Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection.
    Woodle ES; Alloway RR; Hanaway MJ; Buell JF; Thomas M; Roy-Chaudhury P; Trofe J
    Transplant Proc; 2005 Mar; 37(2):798-9. PubMed ID: 15848535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients.
    Vincenti F; Schena FP; Paraskevas S; Hauser IA; Walker RG; Grinyo J;
    Am J Transplant; 2008 Feb; 8(2):307-16. PubMed ID: 18211506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.
    Narayanan M; Pankewycz O; El-Ghoroury M; Shihab F; Wiland A; McCague K; Chan L
    Transplantation; 2013 Feb; 95(4):566-72. PubMed ID: 23423268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.
    Taber DJ; Hunt KJ; Gebregziabher M; Srinivas T; Chavin KD; Baliga PK; Egede LE
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):131-139. PubMed ID: 27979979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.
    Aull MJ; Dadhania D; Afaneh C; Leeser DB; Hartono C; Lee JB; Serur D; Del Pizzo JJ; Suthanthiran M; Kapur S
    Transplantation; 2012 Oct; 94(8):837-44. PubMed ID: 23001353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Augustine JJ; Knauss TC; Bodziak KA; Aeder M; Siegel C; Schulak JA
    Transplantation; 2007 Feb; 83(3):277-81. PubMed ID: 17297401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
    Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G; Wiland AM; Philosophe B; Fink JC; Weir MR; Klassen DK
    Clin Transplant; 2007; 21(4):491-7. PubMed ID: 17645708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression.
    Woodle ES; Alloway RR; Buell JF; Alexander JW; Munda R; Roy-Chaudhury P; First MR; Cardi M; Trofe J
    Am J Transplant; 2005 Nov; 5(11):2740-4. PubMed ID: 16212635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.